Patent · US Expired

Methods of assessing HIV integrase inhibitor therapy

US6958211B2 · kind B2 · utility

121Cited by

4References

6Claims

0Family size

Assignee

Tibotec BVBA · BE

Inventors

Johan Hendrika Jozef Vingerhoets · Wijnegem, BE
Lieve Emma Jan Michiels · Mol, BE
Inge Dierynck · Berchem, BE

Key dates

Filing date	Aug 8, 2002
Grant date	Oct 25, 2005
Priority date	—
Expiry date	Nov 4, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/703
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Methods and products for the evaluation of HIV treatment are provided. The methods are based on evaluating molecular events at the HIV integrase resulting in altered therapeutic efficacy of tho investigated compounds. The methods rely on providing an integrase gene and evaluating either through integrase gene genotyping or phenotyping.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.